Skip to main content
Erschienen in: Langenbeck's Archives of Surgery 1/2004

01.02.2004 | Original Article

Immunogenicity of parathyroid allografts in the rat: immunosuppressive dosages effective in passenger leukocyte-rich small bowel transplants are not effective in parathyroid gland transplants with few passenger leukocytes

verfasst von: S. Timm, C. Otto, D. Begrich, V. Moskalenko, W. Hamelmann, K. Ulrichs, A. Thiede, W. Timmermann

Erschienen in: Langenbeck's Archives of Surgery | Ausgabe 1/2004

Einloggen, um Zugang zu erhalten

Abstract

Background and aims

The passenger leukocytes harboured within an allograft induce a massive allo-immune response that leads to allograft rejection if not countered by immunosuppression. We compared the response to short-term immunosuppression of parathyroid gland transplants possessing few passenger leukocytes with that of passenger leukocyte-rich small bowel transplants.

Methods

Heterotopic parathyroid and orthotopic small bowel transplantation was performed in a Wistar Furth-to-Lewis rat strain combination. Immunosuppression with cyclosporine A (CsA) was administered in different dosages for 14 days. Dysfunctional allografts were examined immunohistologically.

Results

CsA more effectively suppressed the immune response provoked by immunogenic small bowel grafts than that induced by less-immunogenic parathyroid grafts. Immunosuppression with 20 mg/kg per day induced long-term survival in the small bowel (165±21 days) but not in the parathyroid (28±3 days). All rejected grafts featured massive cellular infiltration by activated T cells as a sign of immune rejection.

Conclusion

Immunosuppressive dosages effective in passenger leukocyte-rich small bowel transplants were not as effective in parathyroid gland transplants harbouring few passenger leukocytes. In spite of the paucity of passenger leukocytes in parathyroid grafts it is more difficult to control by immunosuppression the immune response to them than that to the passenger leukocyte-rich small bowel.
Literatur
1.
Zurück zum Zitat Wingert DJ, Friesen SR, Iliopoulos JI, Pierce DE, Thomas JH, Hermreck AS (1986) Post-thyroidectomy hypocalcemia. Am J Surg 152:606–609PubMed Wingert DJ, Friesen SR, Iliopoulos JI, Pierce DE, Thomas JH, Hermreck AS (1986) Post-thyroidectomy hypocalcemia. Am J Surg 152:606–609PubMed
2.
Zurück zum Zitat Arlt W, Fremerey C, Callies F, Reincke M, Schneider P, Timmermann W, Allolio B (2002) Well-being, mood and calcium homeostasis in patients with hypoparathyroidism receiving standard treatment with calcium and vitamin D. Eur J Endocrinol 146:215–222PubMed Arlt W, Fremerey C, Callies F, Reincke M, Schneider P, Timmermann W, Allolio B (2002) Well-being, mood and calcium homeostasis in patients with hypoparathyroidism receiving standard treatment with calcium and vitamin D. Eur J Endocrinol 146:215–222PubMed
3.
Zurück zum Zitat Thomusch O, Machens A, Sekulla C, Ukkat J, Brauckhoff M, Dralle H (2003) The impact of surgical technique on postoperative hypoparathyroidism in bilateral thyroid surgery: a multivariate analysis of 5846 consecutive patients. Surgery 133:180–1853CrossRefPubMed Thomusch O, Machens A, Sekulla C, Ukkat J, Brauckhoff M, Dralle H (2003) The impact of surgical technique on postoperative hypoparathyroidism in bilateral thyroid surgery: a multivariate analysis of 5846 consecutive patients. Surgery 133:180–1853CrossRefPubMed
4.
Zurück zum Zitat Luts L, Sundler F (1998) Autotransplantation of parathyroid glands, a study on morphological changes. Transplantation 66:446–453PubMed Luts L, Sundler F (1998) Autotransplantation of parathyroid glands, a study on morphological changes. Transplantation 66:446–453PubMed
5.
Zurück zum Zitat Hasse C, Zielke A, Klöck G, Schlosser A, Barth P, Zimmermann U, Sitter H, Lorenz W, Rothmund M (1998) Amitogenic alginates: key to first clinical application of microencapsulation technology. World J Surg 22:659–665CrossRefPubMed Hasse C, Zielke A, Klöck G, Schlosser A, Barth P, Zimmermann U, Sitter H, Lorenz W, Rothmund M (1998) Amitogenic alginates: key to first clinical application of microencapsulation technology. World J Surg 22:659–665CrossRefPubMed
6.
Zurück zum Zitat Hasse C, Klöck G, Schlosser A, Zimmermann U, Rothmund M (1997) Parathyroid allotransplantation without immunosuppression. Lancet 350:1296–1297PubMed Hasse C, Klöck G, Schlosser A, Zimmermann U, Rothmund M (1997) Parathyroid allotransplantation without immunosuppression. Lancet 350:1296–1297PubMed
7.
Zurück zum Zitat Saxe AW, Gibson G, Elfont E (1990) In vitro assessment of parathyroid immunogenicity: the effect of cryopreservation. Surgery 108:56–62PubMed Saxe AW, Gibson G, Elfont E (1990) In vitro assessment of parathyroid immunogenicity: the effect of cryopreservation. Surgery 108:56–62PubMed
8.
Zurück zum Zitat Wozniewicz B, Migaj M, Giera B, Prokurat A, Tollczko T, Sawichi A, Nawrot J, Gorski A, Zabritkowska T, Kossakowska AE (1996) Cell culture of human parathyroid cells. Transplant Proc 28:3542–3544PubMed Wozniewicz B, Migaj M, Giera B, Prokurat A, Tollczko T, Sawichi A, Nawrot J, Gorski A, Zabritkowska T, Kossakowska AE (1996) Cell culture of human parathyroid cells. Transplant Proc 28:3542–3544PubMed
9.
Zurück zum Zitat Timm S, Otto C, Gassel A, Hamelmann W, Timmermann W, Ulrichs K, Thiede A (2001) Influence of donor MHC antigen expression on graft survival after rat parathyroid allotransplantation. Langenbecks Arch Surg 386:430–433CrossRefPubMed Timm S, Otto C, Gassel A, Hamelmann W, Timmermann W, Ulrichs K, Thiede A (2001) Influence of donor MHC antigen expression on graft survival after rat parathyroid allotransplantation. Langenbecks Arch Surg 386:430–433CrossRefPubMed
10.
Zurück zum Zitat Rahusen F, Munda R, Hariharan S, First MR, Demmy A (1997) Combined kidney–pancreas and parathyroid transplantation: a case report. Clin Transplant 11:341–343PubMed Rahusen F, Munda R, Hariharan S, First MR, Demmy A (1997) Combined kidney–pancreas and parathyroid transplantation: a case report. Clin Transplant 11:341–343PubMed
11.
Zurück zum Zitat Euvrard S, Kanitakis J, Claudy A (2003) Skin cancers after organ transplantation. N Engl J Med 348:1681–1691CrossRefPubMed Euvrard S, Kanitakis J, Claudy A (2003) Skin cancers after organ transplantation. N Engl J Med 348:1681–1691CrossRefPubMed
12.
Zurück zum Zitat Jenkins FJ, Rowe DT, Rinaldo CR Jr (2003) Herpes virus infections in organ transplant recipients. Clin Diagn Lab Immunol 10:1–7CrossRefPubMed Jenkins FJ, Rowe DT, Rinaldo CR Jr (2003) Herpes virus infections in organ transplant recipients. Clin Diagn Lab Immunol 10:1–7CrossRefPubMed
13.
Zurück zum Zitat Mahalati K, Kahan BD (2000) Pharmacological surrogates of allograft outcome. Ann Transplant 5:14–23 Mahalati K, Kahan BD (2000) Pharmacological surrogates of allograft outcome. Ann Transplant 5:14–23
14.
Zurück zum Zitat Lee KK, Langrehr JM, Stangl MJ, Banner B, Lee TK, Muller A, Schraut WH (1993) Successful treatment of ongoing intestinal allograft rejection permits recovery of graft structure and function. Am J Surg 165:131–136PubMed Lee KK, Langrehr JM, Stangl MJ, Banner B, Lee TK, Muller A, Schraut WH (1993) Successful treatment of ongoing intestinal allograft rejection permits recovery of graft structure and function. Am J Surg 165:131–136PubMed
15.
Zurück zum Zitat Otto C, Gasser M, Waaga-Gasser AM, Rohde AC, Lenhard M, Jost S, Gassel HJ, Ulrichs K, Timmermann W (2002) Prolongation of small bowel allograft survival with a sequential therapy consisting of a synthetic MHC class II peptide and temporarily low-dose cyclosporine A. Hum Immunol 63:880–887CrossRefPubMed Otto C, Gasser M, Waaga-Gasser AM, Rohde AC, Lenhard M, Jost S, Gassel HJ, Ulrichs K, Timmermann W (2002) Prolongation of small bowel allograft survival with a sequential therapy consisting of a synthetic MHC class II peptide and temporarily low-dose cyclosporine A. Hum Immunol 63:880–887CrossRefPubMed
16.
Zurück zum Zitat Timmermann W, Otto C, Gasser M, Meyer D, Parthum E, Schad J, Koch M, Gassel HJ, Ulrichs K, Thiede A (2000) Long-term small bowel allograft function induced by short-term FK 506 application is associated with split tolerance. Transpl Int 13 [Suppl 1]:532–536 Timmermann W, Otto C, Gasser M, Meyer D, Parthum E, Schad J, Koch M, Gassel HJ, Ulrichs K, Thiede A (2000) Long-term small bowel allograft function induced by short-term FK 506 application is associated with split tolerance. Transpl Int 13 [Suppl 1]:532–536
17.
Zurück zum Zitat Timmermann W, Gasser M, Meyer D, Kellersmann R, Gassel H-J, Otto C, Theide A (1999) Progress in experimental intestinal transplantation in small animal models. Acta Gastroenterol Belg 62:216–220PubMed Timmermann W, Gasser M, Meyer D, Kellersmann R, Gassel H-J, Otto C, Theide A (1999) Progress in experimental intestinal transplantation in small animal models. Acta Gastroenterol Belg 62:216–220PubMed
18.
Zurück zum Zitat Schwarzenbach G (1955) The complexones and their analytical application. Analyst 80:713–729 Schwarzenbach G (1955) The complexones and their analytical application. Analyst 80:713–729
19.
Zurück zum Zitat Game DS, Lechler RJ (2002) Pathways of allorecognition: implications for transplantation tolerance. Transpl Immunol 10:101–108CrossRefPubMed Game DS, Lechler RJ (2002) Pathways of allorecognition: implications for transplantation tolerance. Transpl Immunol 10:101–108CrossRefPubMed
20.
Zurück zum Zitat Joosten SA, Van Knoten C, Paul SC (2003) Pathogenesis of chronic allograft rejection. Transpl Int 16:137–145PubMed Joosten SA, Van Knoten C, Paul SC (2003) Pathogenesis of chronic allograft rejection. Transpl Int 16:137–145PubMed
21.
Zurück zum Zitat Fabre JW, Morris PJ (1973) The role of passenger leucocytes in the rejection of renal allografts in the rat. Transplantation 15:631–633PubMed Fabre JW, Morris PJ (1973) The role of passenger leucocytes in the rejection of renal allografts in the rat. Transplantation 15:631–633PubMed
22.
Zurück zum Zitat Sollinger HW, Mack E, Cook K, Belzer FO (1983) Allotransplantation of human parathyroid tissue without immunosuppression. Transplantation 36:599–603PubMed Sollinger HW, Mack E, Cook K, Belzer FO (1983) Allotransplantation of human parathyroid tissue without immunosuppression. Transplantation 36:599–603PubMed
23.
Zurück zum Zitat Decker GA, Stark JH, Botha JR, Margolius LP, Decker G (1995) Allotransplantation of parathyroid cells. Lancet 345:124 Decker GA, Stark JH, Botha JR, Margolius LP, Decker G (1995) Allotransplantation of parathyroid cells. Lancet 345:124
24.
Zurück zum Zitat Sekine Y, Bowen LK, Heidler KM, Van Rooijen N, Brown JW, Cummings OW, Wilkes DS (1997) Role of passenger leukocytes in allograft rejection: effect of depletion of donor alveolar macrophages on the local production of TNF-alpha, T helper 1/T helper 2 cytokines, IgG subclasses, and pathology in a rat model of lung transplantation. J Immunol 159:4084–4093PubMed Sekine Y, Bowen LK, Heidler KM, Van Rooijen N, Brown JW, Cummings OW, Wilkes DS (1997) Role of passenger leukocytes in allograft rejection: effect of depletion of donor alveolar macrophages on the local production of TNF-alpha, T helper 1/T helper 2 cytokines, IgG subclasses, and pathology in a rat model of lung transplantation. J Immunol 159:4084–4093PubMed
26.
Zurück zum Zitat Bjerneroth G, Juhlin C, Rastad J, Akerström G, Klareskog L (1993) MHC class I and II antigen expression on parathyroid tissue and prospects for their allogeneic transplantation. Transplantation 56:717–721PubMed Bjerneroth G, Juhlin C, Rastad J, Akerström G, Klareskog L (1993) MHC class I and II antigen expression on parathyroid tissue and prospects for their allogeneic transplantation. Transplantation 56:717–721PubMed
27.
Zurück zum Zitat Bloom AD, Economou AD, Gebel HM (1986) Indefinite survival of rat parathyroid allografts without postoperative immunosuppression. Surgery 100:1032–1036PubMed Bloom AD, Economou AD, Gebel HM (1986) Indefinite survival of rat parathyroid allografts without postoperative immunosuppression. Surgery 100:1032–1036PubMed
28.
Zurück zum Zitat Niimi M, Takashina M, Takami H, Shirasugi N, Hamano K, Esato K, Matsumoto K, Ikeda Y, Shatari T, Kodaira S, Kameyama K (2000) Experimental parathyroid transplantation: human parathyroid grafts survived and functioned in mice treated with anti-CD4 monoclonal antibody. Biomed Pharmacother 54 [Suppl 1]:80–82 Niimi M, Takashina M, Takami H, Shirasugi N, Hamano K, Esato K, Matsumoto K, Ikeda Y, Shatari T, Kodaira S, Kameyama K (2000) Experimental parathyroid transplantation: human parathyroid grafts survived and functioned in mice treated with anti-CD4 monoclonal antibody. Biomed Pharmacother 54 [Suppl 1]:80–82
29.
Zurück zum Zitat Waaga AM, Chandraker A, Spadafora-Ferreira M, Iyengar A, Khoury S, Carpenter C, Sayhed MH (1998) Mechanisms of indirect allorecognition. Transplantation 65:876–883PubMed Waaga AM, Chandraker A, Spadafora-Ferreira M, Iyengar A, Khoury S, Carpenter C, Sayhed MH (1998) Mechanisms of indirect allorecognition. Transplantation 65:876–883PubMed
30.
Zurück zum Zitat Shoskes DA, Wood KJ (1984) Indirect presentation of MHC antigens in transplantation. Immunol Today 15:32–38CrossRef Shoskes DA, Wood KJ (1984) Indirect presentation of MHC antigens in transplantation. Immunol Today 15:32–38CrossRef
Metadaten
Titel
Immunogenicity of parathyroid allografts in the rat: immunosuppressive dosages effective in passenger leukocyte-rich small bowel transplants are not effective in parathyroid gland transplants with few passenger leukocytes
verfasst von
S. Timm
C. Otto
D. Begrich
V. Moskalenko
W. Hamelmann
K. Ulrichs
A. Thiede
W. Timmermann
Publikationsdatum
01.02.2004
Verlag
Springer-Verlag
Erschienen in
Langenbeck's Archives of Surgery / Ausgabe 1/2004
Print ISSN: 1435-2443
Elektronische ISSN: 1435-2451
DOI
https://doi.org/10.1007/s00423-003-0435-x

Weitere Artikel der Ausgabe 1/2004

Langenbeck's Archives of Surgery 1/2004 Zur Ausgabe

Current Concepts in Clinical Surgery

Incisional abdominal hernia: the open mesh repair

Update Chirurgie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.

S3-Leitlinie „Diagnostik und Therapie des Karpaltunnelsyndroms“

Karpaltunnelsyndrom BDC Leitlinien Webinare
CME: 2 Punkte

Das Karpaltunnelsyndrom ist die häufigste Kompressionsneuropathie peripherer Nerven. Obwohl die Anamnese mit dem nächtlichen Einschlafen der Hand (Brachialgia parästhetica nocturna) sehr typisch ist, ist eine klinisch-neurologische Untersuchung und Elektroneurografie in manchen Fällen auch eine Neurosonografie erforderlich. Im Anfangsstadium sind konservative Maßnahmen (Handgelenksschiene, Ergotherapie) empfehlenswert. Bei nicht Ansprechen der konservativen Therapie oder Auftreten von neurologischen Ausfällen ist eine Dekompression des N. medianus am Karpaltunnel indiziert.

Prof. Dr. med. Gregor Antoniadis
Berufsverband der Deutschen Chirurgie e.V.

S2e-Leitlinie „Distale Radiusfraktur“

Radiusfraktur BDC Leitlinien Webinare
CME: 2 Punkte

Das Webinar beschäftigt sich mit Fragen und Antworten zu Diagnostik und Klassifikation sowie Möglichkeiten des Ausschlusses von Zusatzverletzungen. Die Referenten erläutern, welche Frakturen konservativ behandelt werden können und wie. Das Webinar beantwortet die Frage nach aktuellen operativen Therapiekonzepten: Welcher Zugang, welches Osteosynthesematerial? Auf was muss bei der Nachbehandlung der distalen Radiusfraktur geachtet werden?

PD Dr. med. Oliver Pieske
Dr. med. Benjamin Meyknecht
Berufsverband der Deutschen Chirurgie e.V.

S1-Leitlinie „Empfehlungen zur Therapie der akuten Appendizitis bei Erwachsenen“

Appendizitis BDC Leitlinien Webinare
CME: 2 Punkte

Inhalte des Webinars zur S1-Leitlinie „Empfehlungen zur Therapie der akuten Appendizitis bei Erwachsenen“ sind die Darstellung des Projektes und des Erstellungswegs zur S1-Leitlinie, die Erläuterung der klinischen Relevanz der Klassifikation EAES 2015, die wissenschaftliche Begründung der wichtigsten Empfehlungen und die Darstellung stadiengerechter Therapieoptionen.

Dr. med. Mihailo Andric
Berufsverband der Deutschen Chirurgie e.V.